GlassScriptPhysician profile
Charles Farr
NPI 1205821592
$2,053.64
in general payments reported to CMS, 2019-2025
14 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $661 · 2020: $141 · 2021: $592 · 2022: $532 · 2023: $128.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Gift: $79.69 · Food and Beverage: $48.16.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Gift | $79.69 |
| Food and Beverage | $48.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $512.64 | 2019-2022 | |
| Braintree Laboratories, INC. | $378.39 | 2019-2023 | Sutab |
| Abbvie INC. | $371.21 | 2019-2023 | |
| Intercept Pharmaceuticals, INC. | $223.42 | 2019-2022 | |
| Gilead Sciences, INC. | $154.67 | 2019-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $104.85 | 2019-2020 | |
| Janssen Biotech, INC. | $79.44 | 2021-2022 | |
| Ironwood Pharmaceuticals, INC | $72.28 | 2019-2022 | |
| Ferring Pharmaceuticals INC. | $50.16 | 2019 | |
| Merck Sharp & Dohme LLC | $37.51 | 2020-2022 | |
| Redhill Biopharma INC. | $20.02 | 2020 | |
| Shionogi INC | $18.11 | 2020 | |
| Celgene Corporation | $16.39 | 2021 | |
| Nestle Healthcare Nutrition INC. | $14.55 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Charles Farr listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.